Medical devices and health technologies
PATH's medical devices and health technologies program leads the vanguard in translating innovative ideas into breakthrough health solutions. We accelerate access to affordable, appropriate health solutions to protect and treat the communities that need them most.
Contact
- Tel: 206.285.3500
- innovation@path.org
What we do
Advancing critical health technologies
All too often, existing medical devices and health technologies are inaccessible because they are too expensive or impractical for use in under-resourced health settings. We respond to these challenges by developing and scaling devices and tools with the potential to address the diseases and health issues that disproportionately affect women and children in low-resource settings.
What we do
Our global health impact
Together with our public- and private-sector partners, the Medical Devices and Health Technologies program has investigated hundreds of medical devices, health technologies, and tools and advanced the most promising and appropriate technologies into affordable commercial products for use in country health programs and global health campaigns, reaching billions of people.
We optimize, adapt, test, and validate emerging concepts, technologies, and product formats that optimize vaccine and pharmaceutical efficacy, stability, safety, and ease of use. We develop and qualify analytical assays to support development of stable vaccine and pharmaceutical products. Some examples include oral liquid formulations and sublingual and fast-dissolving tablets.
We identify, assess, advance and introduce medical devices, equipment, and health system innovations for priority health needs in low and middle income countries. We ensure innovations are affordable and accessible for country health systems, including: vaccine supply chain products, maternal and newborn health care devices, infection prevention and control technologies, and other essential health center equipment.
We identify and advance primary packaging and delivery innovations for vaccines and pharmaceuticals that have the potential to maximize efficacy, increase access, and reduce costs. This improves the safety, acceptability, and effectiveness of immunization and drug delivery.
Meet the team
-
Courtney Jarrahian
Global Program Leader
-
Emily Jeffers
Director of Finance and Administration
-
Dr. Manjari Lal
Portfolio Leader: Formulation Technologies
-
Joanie Robertson
Portfolio Leader: Supply Systems and Equipment
-
Jessica Mistilis
Portfolio Leader: Packaging and Delivery Technologies
-
Steven Diesburg
Product Development Engineering Lead
-
Dr. Mercy Mvundura
Technical Advisor Health Economics
-
Rachel Hammack
Communications Manager
-
Betsy Wilskie
Procurement and Supply Technical Assistance Lead